CORD-19:e847d433e7424152a9846673209cb73027415ecd / 331788-331945 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3074","span":{"begin":0,"end":157},"obj":"Sentence"},{"id":"T8298","span":{"begin":0,"end":157},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Insulin resistance and glucose intolerance in HIV-infected subjects during their protease inhibitor treatment: three oral hypoglycemic drugs in comparison L."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T364","span":{"begin":0,"end":157},"obj":"Sentence"}],"text":"Insulin resistance and glucose intolerance in HIV-infected subjects during their protease inhibitor treatment: three oral hypoglycemic drugs in comparison L."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1058","span":{"begin":23,"end":42},"obj":"Disease"},{"id":"T95032","span":{"begin":23,"end":42},"obj":"Disease"}],"attributes":[{"id":"A1058","pred":"mondo_id","subj":"T1058","obj":"http://purl.obolibrary.org/obo/MONDO_0001076"},{"id":"A12280","pred":"mondo_id","subj":"T95032","obj":"http://purl.obolibrary.org/obo/MONDO_0001076"}],"text":"Insulin resistance and glucose intolerance in HIV-infected subjects during their protease inhibitor treatment: three oral hypoglycemic drugs in comparison L."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T376","span":{"begin":0,"end":18},"obj":"Phenotype"},{"id":"T377","span":{"begin":23,"end":42},"obj":"Phenotype"}],"attributes":[{"id":"A376","pred":"hp_id","subj":"T376","obj":"http://purl.obolibrary.org/obo/HP_0000855"},{"id":"A377","pred":"hp_id","subj":"T377","obj":"http://purl.obolibrary.org/obo/HP_0001952"}],"text":"Insulin resistance and glucose intolerance in HIV-infected subjects during their protease inhibitor treatment: three oral hypoglycemic drugs in comparison L."}